Home NDC 0074-3878 EMBLAVEO
Product NDC 0074-3878
11-digit product format 000743878
Labeler code 0074
Product ID 0074-3878_c35160ee-d73c-4288-8172-d69d75d52b1d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name aztreonam and avibactam
Dosage form POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler AbbVie Inc.
Application NDA217906
Marketing category NDA
Marketing start 2025-02-07
Substance AVIBACTAM; AZTREONAM
Active strength 42.3; 127 mg/mL; mg/mL
Pharmacologic classes Monobactam Antibacterial [EPC], Monobactams [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217906-001 EMBLAVEO AVIBACTAM SODIUM; AZTREONAM EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217906-001 NP 2028-02-07 N217906-001 GAIN 2033-02-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 EMBLAVEO EQ 0.5GM BASE/VIAL;1.5GM/VIAL POWDER / INTRAVENOUS RLD, RS 2025-02-07 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 7112592 2026-01-07 U-4147 Drug substance, Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 7612087 2026-11-12 Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8835455 2030-10-08 Drug product 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8471025 2031-08-12 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 8969566 2032-06-15 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 9284314 2032-06-15 Drug substance 2025-03-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 9695122 2032-06-15 Drug substance, Drug product 2025-03-07 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217906-001 NP 2028-02-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217906-001 GAIN 2033-02-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 NP 2028-02-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217906-001 GAIN 2033-02-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217906-001 NP 2028-02-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217906-001 GAIN 2033-02-07 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 NP 2028-02-07 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217906-001 GAIN 2033-02-07 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base EMBLAVEO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AZTREONAM 42.3 mg/mL AVIBACTAM 127 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination G2B4VE5GH8 Internal UNII lookup 7352665165 Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0074-3878-01 EMBLAVEO 12 mL in 1 VIAL, SINGLE-DOSE POWDER, FOR SOLUTION 12 5 0074-3878-10 EMBLAVEO 10 in 1 CARTON POWDER, FOR SOLUTION 10 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0074-3878 EMBLAVEO (AZTREONAM AND AVIBACTAM) POWDER, FOR SOLUTION [ABBVIE INC.] 3 Current NDC, 2 package rows 20250524_be1a6c99-d4b3-46d7-9e99-6e5f9fab556a.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0074-3878-01 00074387801 12 mL in 1 VIAL, SINGLE-DOSE 12 ml Historical 0074-3878-10 00074387810 10 VIAL, SINGLE-DOSE in 1 CARTON (0074-3878-10) / 12 mL in 1 VIAL, SINGLE-DOSE (0074-3878-01) 2025-02-07 No No Current